{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:53:11Z","timestamp":1782330791801,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4913,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jpainsymman.2006.01.013","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T02:01:00Z","timestamp":1154224860000},"page":"175-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine"],"prefix":"10.1016","volume":"32","author":[{"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Villari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Aielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Verna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2006.01.013_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib2","series-title":"Buprenorphine in pain therapy","first-page":"71","article-title":"Cancer pain\/palliative care","author":"Mercadante","year":"2005"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2005.02.002","article-title":"Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","volume":"9","author":"Kogel","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib4","first-page":"S78","article-title":"Comparison of transdermal and sublingual buprenorphine: results from a phase III, randomized, double-blind, placebo-controlled multicenter study in patients with chronic pain","volume":"20","author":"Sorge","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jpainsymman.2003.09.006","article-title":"Safety and effectiveness of intravenous morphine for episodic breakthrough pain, using a fixed ratio with the oral daily morphine dose","volume":"27","author":"Mercadante","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.10249","article-title":"Episodic (breakthrough) pain","volume":"94","author":"Mercadante","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib10","series-title":"Buprenorphine in pain therapy","first-page":"3","article-title":"Basic pharmacology of buprenorphine","author":"Cowan","year":"2005"},{"key":"10.1016\/j.jpainsymman.2006.01.013_bib11","series-title":"Opioids in the treatment of cancer pain","first-page":"81","article-title":"The efficacy in sequential use of buprenorphine and morphine in advanced cancer pain","author":"Atkinson","year":"1990"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392406002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:57:39Z","timestamp":1760129859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392406002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0885392406002764"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.01.013","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}